A Conceptual Framework for Optimizing Pharmaceutical Logistics in Resource-Constrained Public Health Systems Across Sub-Saharan Africa

References

[1] B. O Otokiti, “View article.” [Online]. Available: https://scholar.google.com/citations?view_op= view_citation&hl=en&user=alrU_- gAAAAJ&citation_for_view=alrU_- gAAAAJ:KxtntwgDAa4C

[2] J. T. Bram, B. Warwick-Clark, E. Obeysekare, and K. Mehta, “Utilization and Monetization of Healthcare Data in Developing Countries,” Big Data, vol. 3, no. 2, pp. 59–66, Jun. 2015, 10.1089/big.2014.0053.

[3] J. H. McCoy and H. L. Lee, “Using Fairness Models to Improve Equity in Health Delivery Fleet Management,” Prod. Oper. Manag., vol. 23, no. 6, pp. 965–977, Jun. 2014, 10.1111/poms.12101.

[4] P. Awor, “Urgent Needs: A Literature Review of Strategies for Sustainable Access to Anti- Retroviral Therapy for HIV/AIDS Patients in Sub-Saharan Africa,” Master’s Thesis, The University of Bergen, 2009. [Online]. Available: https://bora.uib.no/bora- xmlui/handle/1956/15849

[5] P. Ajonbadi, H.A, Otokiti, B. O, and Adebayo, “The Efficacy of Planning on Organisational Performance in the Nigeria SMEs.” [Online]. Available: https://scholar.google.com/citations?view_op= view_citation&hl=en&user=alrU_- gAAAAJ&citation_for_view=alrU_- gAAAAJ:nb7KW1ujOQ8C

[6] H. A. Ajonbadi, B. A. Mojeed-Sanni, and B. O. Otokiti, “Sustaining Competitive Advantage in Medium-sized Enterprises (MEs) through Employee Social Interaction and Helping Behaviours,” J. Small Bus. Entrep. Dev., vol. 3, no. 2, 2015,

[7] I. Barton, A. L. Avanceña, N. Gounden, and R. Anupindi, “Unintended consequences and hidden obstacles in medicine access in Sub- Saharan Africa,” Front. Public Health, vol. 7, p. 342, 2019.

[8] A. A. Lawal, H. A. Ajonbadi, and B. O. Otokiti, “Strategic importance of the Nigerian small and medium enterprises (SMES): Myth or reality”.

[9] H. Zakumumpa, J. Rujumba, J. Kwiringira, C. Katureebe, and N. Spicer, “Understanding implementation barriers in the national scale- up of differentiated ART delivery in Uganda,” BMC Health Serv. Res., vol. 20, no. 1, p. 222, Dec. 2020,

[10] Akinbola, Olufemi Amos; Otokiti, Bisayo Oluwatosin; Akinbola, Omolola Sariat; Sanni, Sekinat Arike., “NEXUS OF BORN GLOBAL ENTREPRENEURSHIP FIRMS AND ECONOMIC DEVELOPMENT IN NIGERIA - ProQuest.” [Online]. Available: https://www.proquest.com/openview/81adc74 d18d0d149474095698194233a/1?pq- origsite=gscholar&cbl=5261234

[11] L. R. Østergaard, “Trust matters: A narrative literature review of the role of trust in health care systems in sub-Saharan Africa,” Glob. Public Health, vol. 10, no. 9, pp. 1046–1059, Oct. 2015, 10.1080/17441692.2015.1019538.

[12] B. O. Otokiti, “Mode of Entry of Multinational Corporation and their Performance in the Nigeria Market,” PhD Thesis, Covenant University, 2012. [Online]. Available: https://scholar.google.com/scholar?cluster=95 73900037960593687&hl=en&oi=scholarr

[13] A. Jbaily et al., “Toward health system strengthening in low- and middle-income countries: insights from mathematical modeling of drug supply chains,” BMC Health Serv. Res., vol. 20, no. 1, p. 776, Dec. 2020,

[14] O. Amos, O. Adeniyi, and B. Oluwatosin, “MARKET BASED CAPABILITIES AND RESULTS: INFERENCE FOR TELECOMMUNICATION SERVICE BUSINESSES IN NIGERIA,” 2014.

[15] P. Chivenge, T. Mabhaudhi, A. T. Modi, and P. Mafongoya, “The potential role of neglected and underutilised crop species as future crops under water scarce conditions in Sub-Saharan Africa,” Int. J. Environ. Res. Public. Health, vol. 12, no. 6, pp. 5685–5711, 2015.

[16] N.-H. Z. Leung, A. Chen, P. Yadav, and J. Gallien, “The impact of inventory management on stock-outs of essential drugs in Sub-Saharan Africa: secondary analysis of a field experiment in Zambia,” PloS One, vol. 11, no. 5, p. e0156026, 2016.

[17] A. A. Lawal, H. A. Ajonbadi, and B. O. Otokiti, “Leadership and organisational performance in the Nigeria small and medium enterprises (SMEs)”.

[18] I. Kabore et al., “The Effect of Community- Based Support Services on Clinical Efficacy and Health-Related Quality of Life in HIV/AIDS Patients in Resource-Limited Settings in Sub-Saharan Africa,” AIDS Patient Care STDs, vol. 24, no. 9, pp. 581–594, Sep. 2010,

[19] A. Sharma, B. I. Adekunle, J. C. Ogeawuchi, A. A. Abayomi, and O. Onifade, “IoT-enabled Predictive Maintenance for Mechanical Systems: Innovations in Real-time Monitoring and Operational Excellence,” vol. 2, no. 12, 2019.

[20] F. S. Sarfo and B. Ovbiagele, “Stroke minimization through additive anti- atherosclerotic agents in routine treatment (SMAART): A pilot trial concept for improving stroke outcomes in sub-Saharan Africa,” J. Neurol. Sci., vol. 377, pp. 167–173, 2017.

[21] B. O. Otokiti and O. A. Akinbola, “Effects of Lease Options on the Organizational Growth of Small and Medium Enterprise (SME’s) in Lagos State, Nigeria,” Asian J. Bus. Manag. Sci., vol. 3, no. 4, pp. 1–12, 2013.

[22] A. D. Harries, R. Zachariah, S. D. Lawn, and S. Rosen, “Strategies to improve patient retention on antiretroviral therapy in sub‐Saharan Africa,” Trop. Med. Int. Health, vol. 15, no. s1, pp. 70–75, Jun. 2010, 3156.2010.02506.x.

[23] B. I. Ashiedu, E. Ogbuefi, U. S. Nwabekee, J. C. Ogeawuchi, and A. A. Abayomi, “Developing Financial Due Diligence Frameworks for Mergers and Acquisitions in Emerging Telecom Markets,” vol. 4, no. 1, 2020.

[24] B. Bhattacharya, L. Lin, R. Batta, and P. K. Ram, “Stock-out severity index: tool for evaluating inequity in drug stock-outs,” Cent. Eur. J. Oper. Res., vol. 28, no. 4, pp. 1243– 1263, Dec. 2020, 00634-z.

[25] O. O. Fagbore, J. C. Ogeawuchi, O. Ilori, N. J. Isibor, A. Odetunde, and B. I. Adekunle, “Developing a Conceptual Framework for Financial Data Validation in Private Equity Fund Operations,” vol. 4, no. 5, 2020.

[26] T. Egharevba, “Stakeholder perceptions towards conducting pharmaceutical industry- sponsored clinical trials in Sub-Saharan Africa,” PhD Thesis, University of Glasgow, 2017. [Online]. Available: https://theses.gla.ac.uk/8451/

[27] “Designing Inclusive and Scalable Credit Delivery Systems Using AI-Powered Lending Models for Underserved Markets.” [Online]. Available: https://scholar.google.com/citations?view_op= view_citation&hl=en&user=alrU_- gAAAAJ&cstart=20&pagesize=80&citation_f or_view=alrU_-gAAAAJ:5awf1xo2G04C

[28] K. Outterson, “Should access to medicines and TRIPS flexibilities be limited to specific diseases?,” Am. J. Law Med., vol. 34, no. 2–3, pp. 279–301, 2008.

[29] N. M. Mbeye, O. Adetokunboh, E. Negussie, T. Kredo, and C. S. Wiysonge, “Shifting tasks from pharmacy to non-pharmacy personnel for providing antiretroviral therapy to people living with HIV: a systematic review and meta- analysis,” BMJ Open, vol. 7, no. 8, p. e015072, 2017.

[30] O. T. Odofin, O. A. Agboola, E. Ogbuefi, J. C. Ogeawuchi, O. S. Adanigbo, and T. P. Gbenle, “Conceptual Framework for Unified Payment Integration in Multi-Bank Financial Ecosystems,” vol. 3, no. 12, 2020.

[31] B. Ojikutu, A. Tariro Makadzange, and T. Gaolathe, “Scaling up ART treatment capacity: Lessons learned from South Africa, Zimbabwe, and Botswana,” Curr. Infect. Dis. Rep., vol. 10, no. 1, pp. 69–73, Jan. 2008, 10.1007/s11908-008-0012-0.

[32] Otokiti B.O, “Business Regulation and Control in Nigeria..” [Online]. Available: https://scholar.google.com/citations?view_op= view_citation&hl=en&user=alrU_- gAAAAJ&citation_for_view=alrU_- gAAAAJ:UxriW0iASnsC

[33] D. W. Taylor and C. Ward, “Rule of Law and State Capacity: Keys to Market Access in Developing and Resource -Constrained Markets,” Pharm. Med., vol. 30, no. 4, pp. 193– 201, Aug. 2016, 0149-3.

[34] Oladuji T.J. Nwangele C.R., Onifade O., Akintobi A.O., “Advancements in Financial Forecasting Models: Using AI for Predictive Business Analysis in Emerging Economies.” [Online]. Available: https://scholar.google.com/citations?view_op= view_citation&hl=en&user=Zm0csPMAAAA J&cstart=20&pagesize=80&authuser=1&citati on_for_view=Zm0csPMAAAAJ:Zph67rFs4h oC

[35] T. Ensor and S. Weinzierl, “Regulating health care in low-and middle-income countries: Broadening the policy response in resource constrained environments,” Soc. Sci. Med., vol. 65, no. 2, pp. 355–366, 2007.

[36] Bisayo Otokiti, “A study of management practices and organisational performance of selected MNCs in emerging market - A Case of Nigeria.” [Online]. Available: https://scholar.google.com/citations?view_op= view_citation&hl=en&user=alrU_- gAAAAJ&citation_for_view=alrU_- gAAAAJ:CHSYGLWDkRkC

[37] M. Lemoine, S. Eholié, and K. Lacombe, “Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach,” J. Hepatol., vol. 62, no. 2, pp. 469– 476, 2015.

[38] O. E. Akpe, J. C. Ogeawuchi, A. A. Abayomi, O. A. Agboola, and E. Ogbuefi, “A Conceptual Framework for Strategic Business Planning in Digitally Transformed Organizations,” Iconic Res. Eng. J., vol. 5, no. 4, pp. 310–325, Oct. 2021.

[39] K. Hoppu, S. S. Ranganathan, and A. N. Dodoo, “Realities of paediatric pharmacotherapy in the developing world,” Arch. Dis. Child., vol. 96, no. 8, pp. 764–768, 2011.

[40] L. Hasselback, J. Crawford, T. Chaluco, S. Rajagopal, W. Prosser, and N. Watson, “Rapid diagnostic test supply chain and consumption study in Cabo Delgado, Mozambique: estimating stock shortages and identifying drivers of stock-outs,” Malar. J., vol. 13, no. 1, p. 295, Dec. 2014, 295.

[41] H. A. Ajonbadi and B. Mojeed-Sanni, “A & Otokiti, BO (2015).‘Sustaining Competitive Advantage in Medium-sized Enterprises (MEs) through Employee Social Interaction and Helping Behaviours.,’” J. Small Bus. Entrep. Dev., vol. 3, no. 2, pp. 89–112.

[42] R. Ravinetto, W. Pinxten, and L. Rägo, “Quality of medicines in resource-limited settings: need for ethical guidance,” Glob. Bioeth., vol. 29, no. 1, pp. 81–94, Jan. 2018,

[43] E. O. Ogunnowo, M. A. Adewoyin, J. E. Fiemotongha, T. O. Igunma, and A. K. Adeleke, “Systematic Review of Non- Destructive Testing Methods for Predictive Failure Analysis in Mechanical Systems,” vol. 4, no. 4, 2020.

[44] T. Avafia, “Public health related TRIPS flexibilities and South-South co-operation as enablers of treatment access in Eastern and Southern Africa: perspectives from producing and importing countries,” PhD Thesis, Queen Mary University of London, 2015. [Online]. Available: https://qmro.qmul.ac.uk/xmlui/handle/123456 789/8945

[45] M. A. Adewoyin, E. O. Ogunnowo, J. E. Fiemotongha, T. O. Igunma, and A. K. Adeleke, “Advances in Thermofluid Simulation for Heat Transfer Optimization in Compact Mechanical Devices,” vol. 4, no. 6, 2020.

[46] G. Cometto, A. B. Zaheer-Ud-Din Babar, L. Hedman, and J. Campbell, “PtD) Global Conference on Human Resources in Supply Chain Management,” J. Pharm. Policy Pract., vol. 7, no. 1, p. I1, 2014.

[47] M. A. Adewoyin, E. O. Ogunnowo, J. E. Fiemotongha, T. O. Igunma, and A. K. Adeleke, “A Conceptual Framework for Dynamic Mechanical Analysis in High- Performance Material Selection,” vol. 4, no. 5, 2020.

[48] T. B. Phume and Z. Worku, “Predictors of Efficiency in the Supply Chain Management of Essential Medicines,” 2017, [Online]. Available: https://www.academia.edu/download/8644360 6/73718bff38e5f44920b05a5ad5514b55535f.p df

[49] Persing et al., Eds., “Point-of-Care Medical Device Connectivity: Developing World Landscape,” in Molecular Microbiology, American Society of Microbiology, 2016, pp. 685–691.

[50] B. Plan, “PHARMACEUTICAL MANUFACTURING PLAN FOR AFRICA”, [Online]. Available: https://au.int/sites/default/files/documents/302 19-doc-pmpa_bp_ebook.pdf

[51] S. C. Stender and A. Christensen, “Patient- centered primary health care: synergy potential for health systems strengthening,” Int. J. Tuberc. Lung Dis., vol. 17, no. 10, pp. 15–21, 2013.

[52] P. Kanavos, P. Das, V. Durairaj, R. Laing, and D. O. Abegunde, “Options for financing and optimizing medicines in resource-poor countries,” World Health Rep., 2010, [Online]. Available: https://www.researchgate.net/profile/Varathar ajan-Durairaj/publication/234058035

[53] B. O. Anderson et al., “Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010,” Lancet Oncol., vol. 12, no. 4, pp. 387–398, 2011.

[54] B. S. Bhattacharya, “On Equitably Reducing Stock-Outs for Essential Pharmaceuticals in Low-Resource Countries,” PhD Thesis, State University of New York at Buffalo, 2019. [Online]. Available: https://search.proquest.com/openview/73ebed edc349e41b87e50079e7917495/1?pq- origsite=gscholar&cbl=18750&diss=y

[55] M. P. Bravo et al., “Monitoring Pharmacy and Test Kit Stocks in Rural Mozambique: U.S. President’s Emergency Plan for AIDS Relief Surveillance to Help Prevent Ministry of Health Shortages,” AIDS Res. Hum. Retroviruses, vol. 36, no. 5, pp. 415–426, May 2020,

[56] T. Mercer et al., “Mitigating The Burden Of Diabetes In Sub-Saharan Africa Through An Integrated Diagonal Health Systems Approach,” Diabetes Metab. Syndr. Obes. Targets Ther., vol. Volume 12, pp. 2261–2272, Oct. 2019,

[57] M. Bigdeli, D. Peters, and A. Wagner, “Medicines in health systems,” Geneva World Health Organ., vol. 117, 2014, [Online]. Available: https://www.haiasiapacific.org/wp- content/uploads/2014/11/MedsinHealthSyste msReport2014.pdf

[58] W. Kaplan and R. Laing, “Local production of pharmaceuticals: industrial policy and access to medicines, an overview of key concepts, issues and opportunities for future research,” 2005, [Online]. Available: https://openknowledge.worldbank.org/entities/ publication/9f9f4bc2-5ae3-5db2-aa3e- 56731e5d64ad

[59] R. O. Makanjuola and A. W. Taylor-Robinson, “Improving Accuracy of Malaria Diagnosis in Underserved Rural and Remote Endemic Areas of Sub-Saharan Africa: A Call to Develop Multiplexing Rapid Diagnostic Tests,” Scientifica, vol. 2020, pp. 1–7, Feb. 2020, 10.1155/2020/3901409.

[60] A. J. Lankowski, M. J. Siedner, D. R. Bangsberg, and A. C. Tsai, “Impact of Geographic and Transportation-Related Barriers on HIV Outcomes in Sub-Saharan Africa: A Systematic Review,” AIDS Behav., vol. 18, no. 7, pp. 1199–1223, Jul. 2014, 10.1007/s10461-014-0729-8.

[61] R. Harding et al., “Generating an African palliative care evidence base: the context, need, challenges, and strategies,” J. Pain Symptom Manage., vol. 36, no. 3, pp. 304–309, 2008.

[62] J. Hill et al., “Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis,” PLoS Med., vol. 10, no. 7, p. e1001488, 2013.

[63] M. A. Jafry et al., “Examination of patient flow in a rural health center in Malawi,” BMC Res. Notes, vol. 9, no. 1, p. 363, Dec. 2016, 10.1186/s13104-016-2144-x.

[64] A. Ramanujapuram and C. K. Malemarpuram, “Enabling sustainable behaviors of data recording and use in low-resource supply chains,” in Proceedings of the 3rd ACM SIGCAS Conference on Computing and Sustainable Societies, Ecuador: ACM, Jun. 2020, pp. 65 –75. 10.1145/3378393.3402248.

[65] A. Haque, B. Kouriba, N. Aïssatou, and A. Pant, “Eliminating cervical cancer in Mali and Senegal, two sub-Saharan countries: Insights and optimizing solutions,” Vaccines, vol. 8, no. 2, p. 181, 2020.

[66] S. D. Lawn, A. D. Harries, X. Anglaret, L. Myer, and R. Wood, “Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa,” Aids, vol. 22, no. 15, pp. 1897–1908, 2008.

[67] H. Parvin, S. Beygi, J. E. Helm, P. S. Larson, and M. P. Van Oyen, “Distribution of Medication Considering Information, Transshipment, and Clustering: Malaria in Malawi,” Prod. Oper. Manag., vol. 27, no. 4, pp. 774–797, Apr. 2018, 10.1111/poms.12826.

[68] N. Konduri et al., “Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals,” Digit. Health, vol. 4, p. 2055207618771407, Jan. 2018, 10.1177/2055207618771407.

[69] S. Pastakia, C. Pekny, S. Manyara, and L. Fischer, “Diabetes in sub-Saharan Africa – from policy to practice to progress: targeting the existing gaps for future care for diabetes,” Diabetes Metab. Syndr. Obes. Targets Ther., vol. Volume 10, pp. 247–263, Jun. 2017,

[70] G. Steel, J. Nwokike, and M. P. Joshi, “Development of a multi-method tool to measure ART adherence in resource - constrained settings: the South Africa experience,” RPM Plus, vol. 6, 2007, [Online]. Available: https://www.researchgate.net/profile/Jude- Nwokike/publication/267362525

[71] M. Abouyannis et al., “Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa,” Aids, vol. 25, no. 13, pp. 1627–1635, 2011.

[72] B. Huysamen, I. H. De Kock, and L. Bam, “DEVELOPING A CHALLENGES LANDSCAPE RELATING TO DRUG SAFETY, PROVISION, AND DISTRIBUTION IN RESOURCE -LIMITED SETTINGS FOR THE CASE OF HIV/AIDS,” South Afr. J. Ind. Eng., vol. 29, no. 3, Nov. 2018,

[73] E. P. Cao, “Decision making in the HIV/AIDS supply chain,” PhD Thesis, Massachusetts Institute of Technology, 2007. [Online]. Available: https://dspace.mit.edu/handle/1721.1/40108

[74] R. Rajasingham, M. A. Rolfes, K. E. Birkenkamp, D. B. Meya, and D. R. Boulware, “Cryptococcal meningitis treatment strategies in resource-limited settings: a cost- effectiveness analysis,” 2012, [Online]. Available: https://journals.plos.org/plosmedicine/article?i d=10.1371/journal.pmed.1001316

[75] N. A. of Sciences, Medicine, M. Division, B. on G. Health, and C. on I. the Q. of H. C. Globally, “Crossing the global quality chasm: improving health care worldwide,” 2018.

[76] A. J. Itiola and K. A. Agu, “Country ownership and sustainability of Nigeria’s HIV/AIDS Supply Chain System: qualitative perceptions of progress, challenges and prospects,” J. Pharm. Policy Pract., vol. 11, no. 1, p. 21, Dec. 2018,

[77] P. Yadav, “Countering Drug Resistance in the Developing World: An Assessment of Incentives Across the Value Chain and Recommendations for Policy Intervention,” Cent. Glob. Dev. Work. Pap., no. 183, 2009, [Online]. Available: https://papers.ssrn.com/sol3/papers.cfm?abstra ct_id=1479669

[78] H. Lüllmann and K. Mohr, Color atlas of pharmacology. Thieme Stuttgart, 1999. [Online]. Available: http://diglib.globalcollege.edu.et:8080/xmlui/b itstream/handle/123456789/1760/pdf.pdf?sequ ence=1&isAllowed=y

[79] A. Wasunna and D. W. Fitzgerald, “Chapter 9: Ethics and Epidemics in the Developing World: The Case of AIDS in Africa: Treatment Challenges,” in Advances in Bioethics, vol. 9, Bingley: Emerald (MCB UP ), 2006, pp. 189– 207.

[80] W. Xiong, N. Hupert, E. B. Hollingsworth, M. E. O’Brien, J. Fast, and W. R. Rodriguez, “Can modeling of HIV treatment processes improve outcomes? Capitalizing on an operations research approach to the global pandemic,” BMC Health Serv. Res., vol. 8, no. 1, p. 166, Dec. 2008,

[81] L. Barro et al., “Blood transfusion in sub‐ Saharan Africa: understanding the missing gap and responding to present and future challenges,” Vox Sang., vol. 113, no. 8, pp. 726–736, Nov. 2018,

[82] B. Jawhari, D. Ludwick, L. Keenan, D. Zakus, and R. Hayward, “Benefits and challenges of EMR implementations in low resource settings: a state-of-the-art review,” BMC Med. Inform. Decis. Mak., vol. 16, no. 1, p. 116, Dec. 2016,

[83] A. Selin, E. J. Mills, and J. B. Nachega, “Barriers to Highly Active Antiretroviral Therapy Adherence in Sub-Saharan Africa,” Future HIV Ther., vol. 1, no. 3, pp. 331–339, Sep. 2007,

[84] A. Anema et al., “Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries,” Public Health Nutr., vol. 15, no. 5, pp. 938–947, 2012.

[85] L. E. Brown, “Applying stated-preference methods to health systems problems in sub- Saharan Africa,” PhD Thesis, Johns Hopkins University, 2018. [Online]. Available: https://jscholarship.library.jhu.edu/bitstream/1 774.2/59160/1/BROWN-DISSERTATION- 2018.pdf

[86] K. W. Ruud, S. C. Srinivas, and E.-L. Toverud, “Antiretroviral therapy in a South African public health care setting–facilitating and constraining factors.,” South. Med Rev., vol. 2, no. 2, 2009, [Online]. Available: https://citeseerx.ist.psu.edu/document?repid=r ep1&type=pdf& 40a0b33f69d6da821c0

[87] B. Eley and J. Nuttall, “Antiretroviral therapy for children: challenges and opportunities,” Ann. Trop. Paediatr., vol. 27, no. 1, pp. 1–10, Mar. 2007,

[88] P. A. Woodburn, “Analysis of challenges of medical supply chains in sub-Saharan Africa regarding inventory management and transport and distribution,” LondonWestminster Bus. Sch., 2013, [Online]. Available: https://iaphl.org/wp- content/uploads/2016/05/Medical-Supply- Chain- Challenges.Masterthesis.ASchoepperle.pdf

[89] T. Crowley and E. L. Stellenberg, “An evaluation of the adequacy of pharmaceutical services for the provision of antiretroviral treatment in primary health care clinics,” Health SA Gesondheid, vol. 20, no. 1, pp. 83– 90, Jun. 2015, 10.1016/j.hsag.2015.02.004.

[90] V. Kunene and J. Mahlangu, “Access to Systemic Anticancer Treatment and Radiotherapy Services in Sub-Saharan Africa,” in Cancer in Sub-Saharan Africa, O. A. Adedeji, Ed., Cham: Springer International Publishing, 2017, pp. 175–190. 10.1007/978-3-319-52554-9_13.

[91] M. El Said and A. Kapczynski, “Access to medicines: The role of intellectual property law and policy,” 2012, [Online]. Available: https://clok.uclan.ac.uk/12962/?template=defa ult_internal

[92] M. Roy, C. Bolton Moore, I. Sikazwe, and C. B. Holmes, “A Review of Differentiated Service Delivery for HIV Treatment: Effectiveness, Mechanisms, Targeting, and Scale,” Curr. HIV/AIDS Rep., vol. 16, no. 4, pp. 324–334, Aug. 2019, 019-00454-5.

[93] W. H. Organization, The world health report 2006: working together for health. World Health Organization, 2006. [Online]. Available: https://books.google.com/books?hl=en&lr=&i d=taYsDwAAQBAJ&oi=fnd&pg=PR13&dq= Pharmaceutical+logistics,+supply+chain+opti mization,+Sub- Saharan+Africa,+public+health+systems,+res ource- constrained,+access+to+medicines&ots=9gka 2qyjD5&sig=yN- iU6IZ7ZH35K5zMsFkNTsTpJ4

[94] G. Alemnji, P. Fonjungo, B. Van Der Pol, T. Peter, R. Kantor, and J. Nkengasong, “The Centrality of Laboratory Services in the HIV Treatment and Prevention Cascade: The Need for Effective Linkages and Referrals in Resource-Limited Settings,” AIDS Patient Care STDs, vol. 28, no. 5, pp. 268–273, May 2014,

[95] M. Frieden et al., “Setting up a nurse-led model of care for management of hypertension and diabetes mellitus in a high HIV prevalence context in rural Zimbabwe: a descriptive study,” BMC Health Serv. Res., vol. 20, no. 1, p. 486, Dec. 2020, 05351-x.

[96] N. E. Thomford et al., “Pharmacogenomics implications of using herbal medicinal plants on African populations in health transition,” Pharmaceuticals, vol. 8, no. 3, pp. 637–663, 2015.

[97] C. S. Alexander et al., “Implementation of HIV palliative care: interprofessional education to improve patient outcomes in resource- constrained settings, 2004–2012,” J. Pain Symptom Manage., vol. 50, no. 3, pp. 350–361, 2015.

[98] H. Walkowiak and D. Keene, “Expanding the role of pharmacy staff in antiretroviral therapy,” Lay. StronG Found., vol. 249, 2009, [Online]. Available: https://richardmarlink.com/wp- content/uploads/2020/03/FromTheGroundUp_ Vol.1.pdf#page=283

[99] W. A. Sisay and A. A. Alemayehu, “Determinants of adherence to antiretroviral therapy drugs in the phase of rapid scale-up of antiretroviral treatment in sub-Saharan Africa: the case of Ethiopia,” Fetene GT Mesfin R Antiretrovir. Treat. Sub-Sahar. Afr. Chall. Prospects Ethiop. Organ. Soc. Sci. Res. East. South. Afr. OSSREA, pp. 87–112, 2013.

[100] K. Caines, J. Bataringaya, G. Murindwa, and H. N’jie, “Impact of Public -Private Partnerships Addressing Access to Pharmaceuticals in Low Income Countries: Uganda Pilot Study,” Initiative on Public- Private Partnerships for Health, Global Forum for …, 2003. [Online]. Avai lable: https://www.rhsupplies.org/uploads/tx_rhscpu blications/IPPPH_access%20pharmaceuticals %20PPP_Uganda_2003.pdf

@article{1709391,
      author = {Michael Aduojo Amuta, Muridzo Muonde, Ashiata Yetunde Mustapha, Akachukwu Obianuju Mbata},
      title = {A Conceptual Framework for Optimizing Pharmaceutical Logistics in Resource-Constrained Public Health Systems Across Sub-Saharan Africa},
      journal = {Iconic Research And Engineering Journals},
      year = {2020},
      volume = {4},
      number = {6},
      pages = {212-231},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1709391.pdf},
      abstract = {Efficient pharmaceutical logistics are vital for ensuring the availability, quality, and accessibility of essential medicines within public health systems. In Sub-Saharan Africa, logistical inefficiencies amplified by systemic resource constraints continue to compromise health outcomes. This study presents a conceptual framework tailored to the unique logistical challenges of pharmaceutical distribution in Sub-Saharan African countries. Drawing on socio-technical systems theory, supply chain optimization models, and empirical evidence, the proposed framework integrates infrastructure, governance, digital innovation, human resources, and risk management to optimize pharmaceutical logistics in resource-limited settings. The study synthesizes 100 academic sources, including field-specific contributions and system-wide evaluations, to establish a multidimensional strategy. The methodology incorporates case study analysis, Delphi expert validation, and performance metric mapping. Findings demonstrate the utility of context-sensitive logistics models, particularly those embedding technology and local capacity-building. The framework also supports anticipatory planning for public health emergencies. This article contributes to logistics optimization discourse by aligning strategic planning with the realities of Sub-Saharan African health systems, aiming to strengthen supply chain resilience, equity in drug access, and overall system efficiency.},
      keywords = {Pharmaceutical logistics, supply chain optimization, Sub-Saharan Africa, public health systems, resource-constrained, access to medicines},
      month = {December},
  }